Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype

被引:88
|
作者
Jeong, Hoiseon [1 ]
Ryu, Young-joon [2 ]
An, Jungsuk [3 ]
Lee, Youngseok [1 ]
Kim, Aeree [1 ]
机构
[1] Korea Univ, Coll Med, Dept Pathol, Seoul 136705, South Korea
[2] Univ Ulsan, Asan Med Ctr, Dept Pathol, Seoul, South Korea
[3] Gachon Univ, Gil Hosp, Dept Pathol, Inchon, South Korea
基金
新加坡国家研究基金会;
关键词
breast; carcinoma; epithelial-mesenchymal transition; immunohistochemistry; tissue array analysis; triple-negative; BASAL-LIKE SUBTYPE; TGF-BETA; STEM-CELLS; EMT; PATHWAYS; SUPERIOR; INVASION; SNAIL;
D O I
10.1111/j.1365-2559.2012.04195.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: Epithelialmesenchymal transition (EMT) is characterized by a loss of epithelial nature and the acquisition of a mesenchymal form. The aim of this study was to assess the role of EMT in human mammary carcinogenesis, by performing immunohistochemical studies of EMT markers with tissue microarrays. Methods and results: A total of 492 cases were evaluated and classified as hormone receptor (HR)-positive type, HER2 type and triple-negative (TN) type by the use of immunohistochemistry and in-situ hybridization. We compared these groups in terms of epithelial and mesenchymal marker expression patterns. Of the 102 cases of TN-type breast cancer, 24.5% expressed vimentin, 13.7% expressed N-cadherin, and 9.8% expressed smooth muscle actin (SMA). Of the 221 cases of HR-type breast cancer, 4.1% expressed vimentin, 5.9% expressed N-cadherin, and 0.4% expressed SMA. Regarding epithelial markers, decreased expression was seen in 16.7% of cases for E-cadherin, in 45.1% for cytokeratin (CK)19 and in 60.8% for CK8 and CK18 (CAM5.2) in TN-type breast cancer cases. Decreased expression was seen in 11.8% of cases for E-cadherin, in 6.8% for CK19 and in 3.2% for CAM5.2 in HR-type cases. Conclusions: EMT features were particularly seen in TN-type breast cancer (P < 0.001). EMT was also significantly associated with high histological grade (P < 0.001).
引用
收藏
页码:E87 / E95
页数:9
相关论文
共 50 条
  • [1] Role of epithelial-mesenchymal transition markers in triple-negative breast cancer
    Cheung, Sai Yin
    Boey, Yvonne Jia Yu
    Koh, Valerie Cui Yun
    Thike, Aye Aye
    Lim, Jeffrey Chun Tatt
    Iqbal, Jabed
    Tan, Puay Hoon
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (03) : 489 - 498
  • [2] Epithelial-Mesenchymal Transition Indexes in Triple-Negative Breast Cancer Progression and Metastases
    Kepuladze, Shota
    Burkadze, George
    Kokhreidze, Irakli
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
  • [3] The Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy and the Epithelial-Mesenchymal Transition
    Zapperi, Stefano
    La Porta, Caterina A. M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [4] Epithelial-mesenchymal transition and its regulators are major targets of triple-negative breast cancer
    Al Moustafa, Ala-Eddin
    [J]. CELL ADHESION & MIGRATION, 2013, 7 (05) : 424 - 425
  • [5] CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer
    Zeng, Qiqun
    Li, Weidong
    Lu, Di
    Wu, Zhenzhen
    Duan, Hongxia
    Luo, Yongting
    Feng, Jing
    Yang, Dongling
    Fu, Li
    Yan, Xiyun
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (04) : 1127 - 1132
  • [6] Intercellular Communication Reveals Therapeutic Potential of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer
    Liu, Yang
    Fang, Yu
    Bao, Lili
    Wu, Feng
    Wang, Shilong
    Hao, Siyu
    [J]. BIOMOLECULES, 2022, 12 (10)
  • [7] Differential expression and clinical significance of epithelial-mesenchymal transition markers among different histological types of triple-negative breast cancer
    Zhou, Shuling
    Sun, Xiangjie
    Yu, Lin
    Zhou, Ruoji
    Li, Anqi
    Li, Ming
    Yang, Wentao
    [J]. JOURNAL OF CANCER, 2018, 9 (03): : 604 - 613
  • [8] Role of epithelial–mesenchymal transition markers in triple-negative breast cancer
    Sai Yin Cheung
    Yvonne Jia Yu Boey
    Valerie Cui Yun Koh
    Aye Aye Thike
    Jeffrey Chun Tatt Lim
    Jabed Iqbal
    Puay Hoon Tan
    [J]. Breast Cancer Research and Treatment, 2015, 152 : 489 - 498
  • [9] Phenotypic Heterogeneity of Triple-Negative Breast Cancer Mediated by Epithelial-Mesenchymal Plasticity
    Kvokackova, Barbora
    Remsik, Jan
    Jolly, Mohit Kumar
    Soucek, Karel
    [J]. CANCERS, 2021, 13 (09)
  • [10] Chemotherapeutic stress influences epithelial-mesenchymal transition and stemness in cancer stem cells of triple-negative breast cancer
    Li, X.
    Strietz, J.
    Bleilevens, A.
    Stickeler, E.
    Maurer, J.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E101 - E101